Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1
- Blood. 2014 Oct 30;124(18):2767-74. doi: 10.1182/blood-2014-08-596445.
- 1. Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA;
- 2. Children's Medical Research Institute, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia;
- 3. Beijing Genomics Institute-Shenzhen, Shenzhen, China;
- 4. Haematology Department, Children's Hospital Westmead, Westmead, NSW, Australia;
- 5. Children's Medical Research Institute, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia; Haematology Department, Children's Hospital Westmead, Westmead, NSW, Australia;
- 6. Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
- 7. University of Sydney, Sydney, NSW, Australia; Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; and Western Sydney Genetics Program, Children's Hospital Westmead, Westmead, NSW, Australia.
- 8. University of Sydney, Sydney, NSW, Australia; Western Sydney Genetics Program, Children's Hospital Westmead, Westmead, NSW, Australia.
Telomerase is a ribonucleoprotein enzyme that is necessary for overcoming telomere shortening in human germ and stem cells. Mutations in Telomerase or other telomere-maintenance proteins can lead to diseases characterized by depletion of hematopoietic stem cells and bone marrow failure (BMF). Telomerase localization to telomeres requires an interaction with a region on the surface of the telomere-binding protein TPP1 known as the TEL patch. Here, we identify a family with aplastic anemia and other related hematopoietic disorders in which a 1-amino-acid deletion in the TEL patch of TPP1 (ΔK170) segregates with disease. All family members carrying this mutation, but not those with wild-type TPP1, have short telomeres. When introduced into 293T cells, TPP1 with the ΔK170 mutation is able to localize to telomeres but fails to recruit Telomerase to telomeres, supporting a causal relationship between this TPP1 mutation and bone marrow disorders. ACD/TPP1 is thus a newly identified telomere-related gene in which mutations cause aplastic anemia and related BMF disorders.